Abstract
Background: Excess vascular deaths in the PLATO trial comparing ticagrelor to clopidogrel have been repeatedly challenged by the Food and Drug Adminis......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
